February 2014 Vol. 6 Issue 21

Abstracts & Commentary

American Ginseng Improves Cancer-related Fatigue

by Michael Traub, ND, DHANP, FABNO  In this 8-week multisite, randomized, double-blind, placebo-controlled study using 1000 mg twice daily of Panax quinquefolius (American ginseng) vs placebo in cancer patients with cancer-related fatigue, fatigue symptoms, secondary outcomes, and toxicities were assessed. At the end of the trial, the group receiving ginseng demonstrated significant improvement in fatigue with greater benefit reported in patients receiving active treatment than those who had completed treatment.

New Evidence Suggests Chemoprevention Activity of Green Tea Supplements

by Lise Alschuler, ND, FABNO  In a presurgical trial of postmenopausal female breast cancer patients comparing green tea capsule supplementation to no green tea supplementation, it was found that patients who consumed green tea supplements experienced a decrease in Ki-67 activity in benign cells and malignant cells compared to patients in the control group.

Flaxseeds Reduce Prostate Cancer Aggressiveness

by Tina Kaczor, ND, FABNO  This small study reminds us that cancerous growth, no matter what stage, is dynamic and may be influenced by lifestyle choices.

Leaky Gut and Chemo

by Jacob Schor, ND, FABNO  Traditionally, one of the goals of naturopathic support for people undergoing chemo has been to help prevent diarrhea and leaky gut. But this study suggests such tactics may actually be working against the chemotherapy.

Peer-Reviewed Articles

Intravenous Vitamin C in Cancer

by Michael Traub, ND, DHANP, FABNO  New information has become available about the clinical use of intravenous vitamin C in recent years, particularly in its application in cancer. However, great variability in practice persists, reflecting a lack of knowledge of how this treatment should be most safely and effectively employed. This article reviews the forms of nutrients that best balance changes in blood chemistry inherent in this therapy and the appropriate use of B vitamins and glutathione.


Chemotherapy-induced Immunosuppression

by Natural Medicine Journal Nearly all patients receiving broad-based chemotherapy will experience immunosuppression. Chemotherapy, by design, targets rapidly dividing cells. It does not discriminate between cancer cells and other rapidly dividing cells. Heather Zwickey, PhD, recently presented at the Oncology Association of Naturopathic Physicians (OncANP) annual conference on the topic of immunosuppression in patients undergoing chemotherapy. Natural Medicine Journal talked to Zwickey about this important oncology topic.